Clinical trial
An Open-label, Prospective Clinical Trial to Evaluate the Effectiveness and Safety of Sirolimus to Reduce Cyst Growth in ADPKD Patients With Massive Polycystic Liver
NCT01680250 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Prospective Clinical Trial to Evaluate the Effectiveness and Safety of Sirolimus to Reduce Cyst Growth in ADPKD Patients With Massive Polycystic Liver
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- September 30, 2011
- Completion date
- August 31, 2015
- Enrollment
- 44 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.